Modeling neurological diseases using patient-derived induced pluripotent stem cells.
Tarja A Juopperi1, Hongjun Song, Guo-Li Ming
1Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Future Neurology
|July 7, 2011
Summary
Induced pluripotent stem cells (iPSCs) offer new ways to study neurological diseases. Patient-specific iPSCs create models for discovering treatments and advancing cellular therapies for brain disorders.
Area of Science:
- Stem cell biology
- Neuroscience
Background:
- Induced pluripotent stem cells (iPSCs) are derived from reprogrammed somatic cells, mimicking embryonic stem cells.
- The iPSC technology is revolutionizing stem cell research and disease modeling.
Purpose of the Study:
- To review the application of disease-specific iPSCs in modeling neurological disorders.
- To highlight the potential of iPSCs in identifying molecular causes and therapeutic targets for neurodegenerative and neurodevelopmental diseases.
Main Methods:
- Review of recent scientific literature on iPSC technology and neurological disease modeling.
- Focus on in vitro and in vivo applications of patient-specific iPSCs.
Main Results:
- iPSCs enable the creation of in vitro models for studying molecular lesions in neurological diseases.
- Patient-derived iPSCs facilitate toxicity screening and the development of cellular therapies.
- iPSC technology aids in discovering therapeutic targets and compounds for neurological conditions.
Conclusions:
- Disease-specific iPSCs are powerful tools for advancing the understanding and treatment of neurological diseases.
- The potential of iPSCs spans from basic research to clinical applications, including cellular therapy.
Related Concept Videos
01:21EPS and iPS Cells in Disease Research
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
01:06Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.